A novel bed-side measure of brain condition and function
Cerenion Oy develops the world’s ﬁrst practical method for measuring the brain function of intensive care patients. Our Cerenion ART™ technology (pat. pend.) aims to reveal the status of the brain as one simple score – at the bed-side and without requiring any changes to the care of the patient.
The solution works by combining state-of-the-art signal analysis technology with standard electroencephalogram (EEG) measurement and the common pharmacological compounds used in intensive care today.
The technology has the potential of improving both the quality and the cost of intensive care.